NIAID supports global research on infectious diseases, immunology, allergy and transplant science to better understand, prevent, diagnose, and treat related illnesses and conditions. With NIAID support, the discoveries of scientists in the United States and around the world are helping to improve the health of millions of individuals, advance public health policy and clinical practice, protect the United States against infectious disease threats, and promote international wellbeing. In executing its mandate, NIAID helps lead global health research and health diplomacy.
Global research is an integral part of many research projects, programs, initiatives, and other activities implemented by the Institute’s extramural and intramural divisions. The NIAID Office of Global Research (OGR) helps coordinate and facilitate these international activities.
Zika Virus Protein Could Be Vaccine Target—May 19, 2016
Large-Scale HIV Vaccine Trial to Launch in South Africa | see Q&A—May 18, 2016
Media Availability: Zika Virus Damages Placenta, Kills Fetal Mice—May 11, 2016
Investigational Malaria Vaccine Protects Healthy U.S. Adults for More than One Year—May 9, 2016
Statement: World Malaria Day 2016 —April 25, 2016
All Global Research News Releases
News From NIAID-Supported Institutions
Last Updated May 19, 2016